Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase 3 trials.

CONCLUSIONS: Among patients who experienced inadequate responses to ustekinumab, rescue with brodalumab improved skin clearance outcomes compared with continuing ustekinumab. This article is protected by copyright. All rights reserved. PMID: 30328108 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30328108?dopt=Abstract

Source: The British Journal of Dermatology - October 17, 2018 Category: Dermatology Authors: Langley RG, Armstrong AW, Lebwohl MG, Blauvelt A, Hsu S, Tyring S, Rastogi S, Pillai R, Israel R Tags: Br J Dermatol Source Type: research